000			02119nam a22004817a 4500
008			170707s20162016 xxu||||| |||| 00| 0 eng d
022			_a0021-972X
040			_aOvid MEDLINE(R)
099			_a26900641
245			_aLong-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study.
251			_aJournal of Clinical Endocrinology & Metabolism. 101(4):1754-61, 2016 Apr
252			_aJ Clin Endocrinol Metab. 101(4):1754-61, 2016 Apr
253			_aThe Journal of clinical endocrinology and metabolism
260			_c2016
260			_fFY2016
266			_d2017-07-07
501			_aAvailable online through MWHC library: 1999- June 2013, Available in print through MWHC library: 1999 - 2006
520			_aParticipants from DPP/DPPOS were assigned to placebo (n=1082) or metformin (n=1073) for 3.2 years, followed by metformin in the metformin group for 9 years. Metformin use was associated with increased risk of vitamin B12 deficiency.
546			_aEnglish
650			_a*Anemia/ci [Chemically Induced]
650			_a*Diabetes Mellitus, Type 2/pc [Prevention & Control]
650			_a*Hypoglycemic Agents/ae [Adverse Effects]
650			_a*Metformin/ae [Adverse Effects]
650			_a*Vitamin B 12 Deficiency/ci [Chemically Induced]
650			_aAdult
650			_aAged
650			_aFemale
650			_aHomocysteine/bl [Blood]
650			_aHumans
650			_aHypoglycemic Agents/tu [Therapeutic Use]
650			_aMale
650			_aMetformin/tu [Therapeutic Use]
650			_aMiddle Aged
650			_aVitamin B 12/bl [Blood]
651			_aMedStar Health Research Institute
657			_aJournal Article
657			_aMulticenter Study
657			_aRandomized Controlled Trial
700			_aAroda, Vanita R
790			_aAroda VR, Bray GA, Crandall JP, Diabetes Prevention Program Research Group, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, Schade DS, Temprosa MG, White NH
856			_uhttps://dx.doi.org/10.1210/jc.2015-3754 _zhttps://dx.doi.org/10.1210/jc.2015-3754
942			_cART _dArticle
999			_c2464 _d2464